A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
Arakawa Y, Sasaki K, Mineharu Y, Uto M, Mizowaki T, Mizusawa J, Sekino Y, Ono T, Aoyama H, Satomi K, Ichimura K, Kinoshita M, Ohno M, Ito Y, Nishikawa R, Fukuda H, Nishimura Y, Narita Y; Brain Tumor Study Group and Radiation Therapy Study Group of the Japan Clinical Oncology Group.
Arakawa Y, et al. Among authors: mizusawa j.
BMC Cancer. 2021 Oct 15;21(1):1105. doi: 10.1186/s12885-021-08834-0.
BMC Cancer. 2021.
PMID: 34654402
Free PMC article.
Clinical Trial.